The Aroon Indicator for DFAI entered a downward trend on October 19, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 131 similar instances where the Aroon Indicator formed such a pattern. In 106 of the 131 cases the stock moved lower. This puts the odds of a downward move at 81%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DFAI as a result. In 66 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for DFAI turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 35 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
DFAI moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DFAI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +0.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where DFAI advanced for three days, in 273 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
DFAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator for NMR entered a downward trend on November 03, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 138 similar instances where the Aroon Indicator formed such a pattern. In 89 of the 138 cases the stock moved lower. This puts the odds of a downward move at 64%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NMR as a result. In 43 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.
The Moving Average Convergence Divergence Histogram (MACD) for NMR turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 27 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
The RSI Indicator entered the oversold zone -- be on the watch for NMR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +3.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where NMR advanced for three days, in 206 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
NMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. NMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.007) is normal, around the industry mean (3.143). P/E Ratio (0.068) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (0.815) is also within normal values, averaging (0.809). Dividend Yield (0.041) settles around the average of (8.975) among similar stocks. P/S Ratio (2.472) is also within normal values, averaging (17.075).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
NMR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 22 | |
SMR RATING 1..100 | 1 | |
PRICE GROWTH RATING 1..100 | 55 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DFAI | NMR | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | 3 days ago 64% |
| Stochastic ODDS (%) | 3 days ago 80% | 3 days ago 65% |
| Momentum ODDS (%) | 3 days ago 80% | 3 days ago 53% |
| MACD ODDS (%) | 3 days ago 70% | 3 days ago 56% |
| TrendWeek ODDS (%) | 3 days ago 77% | 3 days ago 55% |
| TrendMonth ODDS (%) | 3 days ago 75% | 3 days ago 56% |
| Advances ODDS (%) | 25 days ago 82% | 25 days ago 68% |
| Declines ODDS (%) | 3 days ago 78% | 3 days ago 54% |
| BollingerBands ODDS (%) | 3 days ago 86% | 3 days ago 64% |
| Aroon ODDS (%) | 5 days ago 81% | 3 days ago 64% |
A.I.dvisor indicates that over the last year, DFAI has been closely correlated with BBVA. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if DFAI jumps, then BBVA could also see price increases.
| Ticker / NAME | Correlation To DFAI | 1D Price Change % | ||
|---|---|---|---|---|
| DFAI | 100% | -2.51% | ||
| BBVA - DFAI | 75% Closely correlated | -3.85% | ||
| SAN - DFAI | 75% Closely correlated | -2.37% | ||
| MT - DFAI | 73% Closely correlated | -6.17% | ||
| BHP - DFAI | 71% Closely correlated | -2.00% | ||
| NMR - DFAI | 71% Closely correlated | -5.86% | ||
More | ||||
A.I.dvisor indicates that over the last year, NMR has been loosely correlated with MS. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NMR jumps, then MS could also see price increases.